COVID-19 Impact on Global Eye Disorders Treatments Market Size, Status and Forecast 2020-2026
Most treatment of eye diseases is aimed at reducing inflammation, repairing traumatic injuries and improving or saving eyesight.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Eye Disorders Treatments market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Eye Disorders Treatments industry.
Based on our recent survey, we have several different scenarios about the Eye Disorders Treatments YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Eye Disorders Treatments will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Eye Disorders Treatments market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Eye Disorders Treatments market in terms of revenue.
Players, stakeholders, and other participants in the global Eye Disorders Treatments market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Eye Disorders Treatments market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Eye Disorders Treatments market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Eye Disorders Treatments market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Eye Disorders Treatments market.
The following players are covered in this report:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Eye Disorders Treatments market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Eye Disorders Treatments industry.
Based on our recent survey, we have several different scenarios about the Eye Disorders Treatments YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Eye Disorders Treatments will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Eye Disorders Treatments market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Eye Disorders Treatments market in terms of revenue.
Players, stakeholders, and other participants in the global Eye Disorders Treatments market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Eye Disorders Treatments market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Eye Disorders Treatments market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Eye Disorders Treatments market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Eye Disorders Treatments market.
The following players are covered in this report:
- Johnson & Johnson
- Novartis
- Alimera Sciences
- Teva Pharmaceutical
- Eyetech Pharmaceuticals
- Refocus Group
- VisionCare Ophthalmic Technologies
- Cataract Surgery Devices
- Glaucoma Surgery Devices
- Vitreoretinal Surgery Devices
- Refractive Surgery Devices
- Hospitals
- Clinics
- Others
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Eye Disorders Treatments Revenue
1.4 Market Analysis by Type
1.4.1 Global Eye Disorders Treatments Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cataract Surgery Devices
1.4.3 Glaucoma Surgery Devices
1.4.4 Vitreoretinal Surgery Devices
1.4.5 Refractive Surgery Devices
1.5 Market by Application
1.5.1 Global Eye Disorders Treatments Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Eye Disorders Treatments Industry Impact
1.6.1 How the Covid-19 is Affecting the Eye Disorders Treatments Industry
1.6.1.1 Eye Disorders Treatments Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Eye Disorders Treatments Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Eye Disorders Treatments Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Eye Disorders Treatments Market Perspective (2015-2026)
2.2 Eye Disorders Treatments Growth Trends by Regions
2.2.1 Eye Disorders Treatments Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Eye Disorders Treatments Historic Market Share by Regions (2015-2020)
2.2.3 Eye Disorders Treatments Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Eye Disorders Treatments Market Growth Strategy
2.3.6 Primary Interviews with Key Eye Disorders Treatments Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Eye Disorders Treatments Players by Market Size
3.1.1 Global Top Eye Disorders Treatments Players by Revenue (2015-2020)
3.1.2 Global Eye Disorders Treatments Revenue Market Share by Players (2015-2020)
3.1.3 Global Eye Disorders Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Eye Disorders Treatments Market Concentration Ratio
3.2.1 Global Eye Disorders Treatments Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Eye Disorders Treatments Revenue in 2019
3.3 Eye Disorders Treatments Key Players Head office and Area Served
3.4 Key Players Eye Disorders Treatments Product Solution and Service
3.5 Date of Enter into Eye Disorders Treatments Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Eye Disorders Treatments Historic Market Size by Type (2015-2020)
4.2 Global Eye Disorders Treatments Forecasted Market Size by Type (2021-2026)
5 EYE DISORDERS TREATMENTS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Eye Disorders Treatments Market Size by Application (2015-2020)
5.2 Global Eye Disorders Treatments Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Eye Disorders Treatments Market Size (2015-2020)
6.2 Eye Disorders Treatments Key Players in North America (2019-2020)
6.3 North America Eye Disorders Treatments Market Size by Type (2015-2020)
6.4 North America Eye Disorders Treatments Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Eye Disorders Treatments Market Size (2015-2020)
7.2 Eye Disorders Treatments Key Players in Europe (2019-2020)
7.3 Europe Eye Disorders Treatments Market Size by Type (2015-2020)
7.4 Europe Eye Disorders Treatments Market Size by Application (2015-2020)
8 CHINA
8.1 China Eye Disorders Treatments Market Size (2015-2020)
8.2 Eye Disorders Treatments Key Players in China (2019-2020)
8.3 China Eye Disorders Treatments Market Size by Type (2015-2020)
8.4 China Eye Disorders Treatments Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Eye Disorders Treatments Market Size (2015-2020)
9.2 Eye Disorders Treatments Key Players in Japan (2019-2020)
9.3 Japan Eye Disorders Treatments Market Size by Type (2015-2020)
9.4 Japan Eye Disorders Treatments Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Eye Disorders Treatments Market Size (2015-2020)
10.2 Eye Disorders Treatments Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Eye Disorders Treatments Market Size by Type (2015-2020)
10.4 Southeast Asia Eye Disorders Treatments Market Size by Application (2015-2020)
11 INDIA
11.1 India Eye Disorders Treatments Market Size (2015-2020)
11.2 Eye Disorders Treatments Key Players in India (2019-2020)
11.3 India Eye Disorders Treatments Market Size by Type (2015-2020)
11.4 India Eye Disorders Treatments Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Eye Disorders Treatments Market Size (2015-2020)
12.2 Eye Disorders Treatments Key Players in Central & South America (2019-2020)
12.3 Central & South America Eye Disorders Treatments Market Size by Type (2015-2020)
12.4 Central & South America Eye Disorders Treatments Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview and Its Total Revenue
13.1.3 Johnson & Johnson Eye Disorders Treatments Introduction
13.1.4 Johnson & Johnson Revenue in Eye Disorders Treatments Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis Eye Disorders Treatments Introduction
13.2.4 Novartis Revenue in Eye Disorders Treatments Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Alimera Sciences
13.3.1 Alimera Sciences Company Details
13.3.2 Alimera Sciences Business Overview and Its Total Revenue
13.3.3 Alimera Sciences Eye Disorders Treatments Introduction
13.3.4 Alimera Sciences Revenue in Eye Disorders Treatments Business (2015-2020)
13.3.5 Alimera Sciences Recent Development
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Details
13.4.2 Teva Pharmaceutical Business Overview and Its Total Revenue
13.4.3 Teva Pharmaceutical Eye Disorders Treatments Introduction
13.4.4 Teva Pharmaceutical Revenue in Eye Disorders Treatments Business (2015-2020)
13.4.5 Teva Pharmaceutical Recent Development
13.5 Eyetech Pharmaceuticals
13.5.1 Eyetech Pharmaceuticals Company Details
13.5.2 Eyetech Pharmaceuticals Business Overview and Its Total Revenue
13.5.3 Eyetech Pharmaceuticals Eye Disorders Treatments Introduction
13.5.4 Eyetech Pharmaceuticals Revenue in Eye Disorders Treatments Business (2015-2020)
13.5.5 Eyetech Pharmaceuticals Recent Development
13.6 Refocus Group
13.6.1 Refocus Group Company Details
13.6.2 Refocus Group Business Overview and Its Total Revenue
13.6.3 Refocus Group Eye Disorders Treatments Introduction
13.6.4 Refocus Group Revenue in Eye Disorders Treatments Business (2015-2020)
13.6.5 Refocus Group Recent Development
13.7 VisionCare Ophthalmic Technologies
13.7.1 VisionCare Ophthalmic Technologies Company Details
13.7.2 VisionCare Ophthalmic Technologies Business Overview and Its Total Revenue
13.7.3 VisionCare Ophthalmic Technologies Eye Disorders Treatments Introduction
13.7.4 VisionCare Ophthalmic Technologies Revenue in Eye Disorders Treatments Business (2015-2020)
13.7.5 VisionCare Ophthalmic Technologies Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Eye Disorders Treatments Revenue
1.4 Market Analysis by Type
1.4.1 Global Eye Disorders Treatments Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Cataract Surgery Devices
1.4.3 Glaucoma Surgery Devices
1.4.4 Vitreoretinal Surgery Devices
1.4.5 Refractive Surgery Devices
1.5 Market by Application
1.5.1 Global Eye Disorders Treatments Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): Eye Disorders Treatments Industry Impact
1.6.1 How the Covid-19 is Affecting the Eye Disorders Treatments Industry
1.6.1.1 Eye Disorders Treatments Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Eye Disorders Treatments Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Eye Disorders Treatments Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 GLOBAL GROWTH TRENDS BY REGIONS
2.1 Eye Disorders Treatments Market Perspective (2015-2026)
2.2 Eye Disorders Treatments Growth Trends by Regions
2.2.1 Eye Disorders Treatments Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Eye Disorders Treatments Historic Market Share by Regions (2015-2020)
2.2.3 Eye Disorders Treatments Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Eye Disorders Treatments Market Growth Strategy
2.3.6 Primary Interviews with Key Eye Disorders Treatments Players (Opinion Leaders)
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top Eye Disorders Treatments Players by Market Size
3.1.1 Global Top Eye Disorders Treatments Players by Revenue (2015-2020)
3.1.2 Global Eye Disorders Treatments Revenue Market Share by Players (2015-2020)
3.1.3 Global Eye Disorders Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Eye Disorders Treatments Market Concentration Ratio
3.2.1 Global Eye Disorders Treatments Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Eye Disorders Treatments Revenue in 2019
3.3 Eye Disorders Treatments Key Players Head office and Area Served
3.4 Key Players Eye Disorders Treatments Product Solution and Service
3.5 Date of Enter into Eye Disorders Treatments Market
3.6 Mergers & Acquisitions, Expansion Plans
4 BREAKDOWN DATA BY TYPE (2015-2026)
4.1 Global Eye Disorders Treatments Historic Market Size by Type (2015-2020)
4.2 Global Eye Disorders Treatments Forecasted Market Size by Type (2021-2026)
5 EYE DISORDERS TREATMENTS BREAKDOWN DATA BY APPLICATION (2015-2026)
5.1 Global Eye Disorders Treatments Market Size by Application (2015-2020)
5.2 Global Eye Disorders Treatments Forecasted Market Size by Application (2021-2026)
6 NORTH AMERICA
6.1 North America Eye Disorders Treatments Market Size (2015-2020)
6.2 Eye Disorders Treatments Key Players in North America (2019-2020)
6.3 North America Eye Disorders Treatments Market Size by Type (2015-2020)
6.4 North America Eye Disorders Treatments Market Size by Application (2015-2020)
7 EUROPE
7.1 Europe Eye Disorders Treatments Market Size (2015-2020)
7.2 Eye Disorders Treatments Key Players in Europe (2019-2020)
7.3 Europe Eye Disorders Treatments Market Size by Type (2015-2020)
7.4 Europe Eye Disorders Treatments Market Size by Application (2015-2020)
8 CHINA
8.1 China Eye Disorders Treatments Market Size (2015-2020)
8.2 Eye Disorders Treatments Key Players in China (2019-2020)
8.3 China Eye Disorders Treatments Market Size by Type (2015-2020)
8.4 China Eye Disorders Treatments Market Size by Application (2015-2020)
9 JAPAN
9.1 Japan Eye Disorders Treatments Market Size (2015-2020)
9.2 Eye Disorders Treatments Key Players in Japan (2019-2020)
9.3 Japan Eye Disorders Treatments Market Size by Type (2015-2020)
9.4 Japan Eye Disorders Treatments Market Size by Application (2015-2020)
10 SOUTHEAST ASIA
10.1 Southeast Asia Eye Disorders Treatments Market Size (2015-2020)
10.2 Eye Disorders Treatments Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Eye Disorders Treatments Market Size by Type (2015-2020)
10.4 Southeast Asia Eye Disorders Treatments Market Size by Application (2015-2020)
11 INDIA
11.1 India Eye Disorders Treatments Market Size (2015-2020)
11.2 Eye Disorders Treatments Key Players in India (2019-2020)
11.3 India Eye Disorders Treatments Market Size by Type (2015-2020)
11.4 India Eye Disorders Treatments Market Size by Application (2015-2020)
12 CENTRAL & SOUTH AMERICA
12.1 Central & South America Eye Disorders Treatments Market Size (2015-2020)
12.2 Eye Disorders Treatments Key Players in Central & South America (2019-2020)
12.3 Central & South America Eye Disorders Treatments Market Size by Type (2015-2020)
12.4 Central & South America Eye Disorders Treatments Market Size by Application (2015-2020)
13 KEY PLAYERS PROFILES
13.1 Johnson & Johnson
13.1.1 Johnson & Johnson Company Details
13.1.2 Johnson & Johnson Business Overview and Its Total Revenue
13.1.3 Johnson & Johnson Eye Disorders Treatments Introduction
13.1.4 Johnson & Johnson Revenue in Eye Disorders Treatments Business (2015-2020))
13.1.5 Johnson & Johnson Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview and Its Total Revenue
13.2.3 Novartis Eye Disorders Treatments Introduction
13.2.4 Novartis Revenue in Eye Disorders Treatments Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Alimera Sciences
13.3.1 Alimera Sciences Company Details
13.3.2 Alimera Sciences Business Overview and Its Total Revenue
13.3.3 Alimera Sciences Eye Disorders Treatments Introduction
13.3.4 Alimera Sciences Revenue in Eye Disorders Treatments Business (2015-2020)
13.3.5 Alimera Sciences Recent Development
13.4 Teva Pharmaceutical
13.4.1 Teva Pharmaceutical Company Details
13.4.2 Teva Pharmaceutical Business Overview and Its Total Revenue
13.4.3 Teva Pharmaceutical Eye Disorders Treatments Introduction
13.4.4 Teva Pharmaceutical Revenue in Eye Disorders Treatments Business (2015-2020)
13.4.5 Teva Pharmaceutical Recent Development
13.5 Eyetech Pharmaceuticals
13.5.1 Eyetech Pharmaceuticals Company Details
13.5.2 Eyetech Pharmaceuticals Business Overview and Its Total Revenue
13.5.3 Eyetech Pharmaceuticals Eye Disorders Treatments Introduction
13.5.4 Eyetech Pharmaceuticals Revenue in Eye Disorders Treatments Business (2015-2020)
13.5.5 Eyetech Pharmaceuticals Recent Development
13.6 Refocus Group
13.6.1 Refocus Group Company Details
13.6.2 Refocus Group Business Overview and Its Total Revenue
13.6.3 Refocus Group Eye Disorders Treatments Introduction
13.6.4 Refocus Group Revenue in Eye Disorders Treatments Business (2015-2020)
13.6.5 Refocus Group Recent Development
13.7 VisionCare Ophthalmic Technologies
13.7.1 VisionCare Ophthalmic Technologies Company Details
13.7.2 VisionCare Ophthalmic Technologies Business Overview and Its Total Revenue
13.7.3 VisionCare Ophthalmic Technologies Eye Disorders Treatments Introduction
13.7.4 VisionCare Ophthalmic Technologies Revenue in Eye Disorders Treatments Business (2015-2020)
13.7.5 VisionCare Ophthalmic Technologies Recent Development
14 ANALYST'S VIEWPOINTS/CONCLUSIONS
15 APPENDIX
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
LIST OF TABLES
Table 1. Eye Disorders Treatments Key Market Segments
Table 2. Key Players Covered: Ranking by Eye Disorders Treatments Revenue
Table 3. Ranking of Global Top Eye Disorders Treatments Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Eye Disorders Treatments Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cataract Surgery Devices
Table 6. Key Players of Glaucoma Surgery Devices
Table 7. Key Players of Vitreoretinal Surgery Devices
Table 8. Key Players of Refractive Surgery Devices
Table 9. COVID-19 Impact Global Market: (Four Eye Disorders Treatments Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Eye Disorders Treatments Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Eye Disorders Treatments Players to Combat Covid-19 Impact
Table 14. Global Eye Disorders Treatments Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Eye Disorders Treatments Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Eye Disorders Treatments Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Eye Disorders Treatments Market Share by Regions (2015-2020)
Table 18. Global Eye Disorders Treatments Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Eye Disorders Treatments Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Eye Disorders Treatments Market Growth Strategy
Table 24. Main Points Interviewed from Key Eye Disorders Treatments Players
Table 25. Global Eye Disorders Treatments Revenue by Players (2015-2020) (Million US$)
Table 26. Global Eye Disorders Treatments Market Share by Players (2015-2020)
Table 27. Global Top Eye Disorders Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eye Disorders Treatments as of 2019)
Table 28. Global Eye Disorders Treatments by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Eye Disorders Treatments Product Solution and Service
Table 31. Date of Enter into Eye Disorders Treatments Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 34. Global Eye Disorders Treatments Market Size Share by Type (2015-2020)
Table 35. Global Eye Disorders Treatments Revenue Market Share by Type (2021-2026)
Table 36. Global Eye Disorders Treatments Market Size Share by Application (2015-2020)
Table 37. Global Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 38. Global Eye Disorders Treatments Market Size Share by Application (2021-2026)
Table 39. North America Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 41. North America Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 42. North America Eye Disorders Treatments Market Share by Type (2015-2020)
Table 43. North America Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 44. North America Eye Disorders Treatments Market Share by Application (2015-2020)
Table 45. Europe Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 47. Europe Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Eye Disorders Treatments Market Share by Type (2015-2020)
Table 49. Europe Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Eye Disorders Treatments Market Share by Application (2015-2020)
Table 51. China Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 52. China Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 53. China Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 54. China Eye Disorders Treatments Market Share by Type (2015-2020)
Table 55. China Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 56. China Eye Disorders Treatments Market Share by Application (2015-2020)
Table 57. Japan Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 59. Japan Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Eye Disorders Treatments Market Share by Type (2015-2020)
Table 61. Japan Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Eye Disorders Treatments Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 65. Southeast Asia Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Eye Disorders Treatments Market Share by Type (2015-2020)
Table 67. Southeast Asia Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Eye Disorders Treatments Market Share by Application (2015-2020)
Table 69. India Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 70. India Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 71. India Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 72. India Eye Disorders Treatments Market Share by Type (2015-2020)
Table 73. India Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 74. India Eye Disorders Treatments Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 77. Central & South America Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Eye Disorders Treatments Market Share by Type (2015-2020)
Table 79. Central & South America Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Eye Disorders Treatments Market Share by Application (2015-2020)
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 85. Johnson & Johnson Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Alimera Sciences Company Details
Table 92. Alimera Sciences Business Overview
Table 93. Alimera Sciences Product
Table 94. Alimera Sciences Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 95. Alimera Sciences Recent Development
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Product
Table 99. Teva Pharmaceutical Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 100. Teva Pharmaceutical Recent Development
Table 101. Eyetech Pharmaceuticals Company Details
Table 102. Eyetech Pharmaceuticals Business Overview
Table 103. Eyetech Pharmaceuticals Product
Table 104. Eyetech Pharmaceuticals Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 105. Eyetech Pharmaceuticals Recent Development
Table 106. Refocus Group Company Details
Table 107. Refocus Group Business Overview
Table 108. Refocus Group Product
Table 109. Refocus Group Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 110. Refocus Group Recent Development
Table 111. VisionCare Ophthalmic Technologies Company Details
Table 112. VisionCare Ophthalmic Technologies Business Overview
Table 113. VisionCare Ophthalmic Technologies Product
Table 114. VisionCare Ophthalmic Technologies Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 115. VisionCare Ophthalmic Technologies Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
Table 1. Eye Disorders Treatments Key Market Segments
Table 2. Key Players Covered: Ranking by Eye Disorders Treatments Revenue
Table 3. Ranking of Global Top Eye Disorders Treatments Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Eye Disorders Treatments Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Cataract Surgery Devices
Table 6. Key Players of Glaucoma Surgery Devices
Table 7. Key Players of Vitreoretinal Surgery Devices
Table 8. Key Players of Refractive Surgery Devices
Table 9. COVID-19 Impact Global Market: (Four Eye Disorders Treatments Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for Eye Disorders Treatments Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for Eye Disorders Treatments Players to Combat Covid-19 Impact
Table 14. Global Eye Disorders Treatments Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global Eye Disorders Treatments Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global Eye Disorders Treatments Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global Eye Disorders Treatments Market Share by Regions (2015-2020)
Table 18. Global Eye Disorders Treatments Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global Eye Disorders Treatments Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. Eye Disorders Treatments Market Growth Strategy
Table 24. Main Points Interviewed from Key Eye Disorders Treatments Players
Table 25. Global Eye Disorders Treatments Revenue by Players (2015-2020) (Million US$)
Table 26. Global Eye Disorders Treatments Market Share by Players (2015-2020)
Table 27. Global Top Eye Disorders Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eye Disorders Treatments as of 2019)
Table 28. Global Eye Disorders Treatments by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players Eye Disorders Treatments Product Solution and Service
Table 31. Date of Enter into Eye Disorders Treatments Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 34. Global Eye Disorders Treatments Market Size Share by Type (2015-2020)
Table 35. Global Eye Disorders Treatments Revenue Market Share by Type (2021-2026)
Table 36. Global Eye Disorders Treatments Market Size Share by Application (2015-2020)
Table 37. Global Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 38. Global Eye Disorders Treatments Market Size Share by Application (2021-2026)
Table 39. North America Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 40. North America Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 41. North America Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 42. North America Eye Disorders Treatments Market Share by Type (2015-2020)
Table 43. North America Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 44. North America Eye Disorders Treatments Market Share by Application (2015-2020)
Table 45. Europe Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 47. Europe Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 48. Europe Eye Disorders Treatments Market Share by Type (2015-2020)
Table 49. Europe Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 50. Europe Eye Disorders Treatments Market Share by Application (2015-2020)
Table 51. China Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 52. China Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 53. China Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 54. China Eye Disorders Treatments Market Share by Type (2015-2020)
Table 55. China Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 56. China Eye Disorders Treatments Market Share by Application (2015-2020)
Table 57. Japan Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 59. Japan Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 60. Japan Eye Disorders Treatments Market Share by Type (2015-2020)
Table 61. Japan Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 62. Japan Eye Disorders Treatments Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 65. Southeast Asia Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia Eye Disorders Treatments Market Share by Type (2015-2020)
Table 67. Southeast Asia Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia Eye Disorders Treatments Market Share by Application (2015-2020)
Table 69. India Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 70. India Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 71. India Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 72. India Eye Disorders Treatments Market Share by Type (2015-2020)
Table 73. India Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 74. India Eye Disorders Treatments Market Share by Application (2015-2020)
Table 75. Central & South America Key Players Eye Disorders Treatments Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players Eye Disorders Treatments Market Share (2019-2020)
Table 77. Central & South America Eye Disorders Treatments Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America Eye Disorders Treatments Market Share by Type (2015-2020)
Table 79. Central & South America Eye Disorders Treatments Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America Eye Disorders Treatments Market Share by Application (2015-2020)
Table 81. Johnson & Johnson Company Details
Table 82. Johnson & Johnson Business Overview
Table 83. Johnson & Johnson Product
Table 84. Johnson & Johnson Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 85. Johnson & Johnson Recent Development
Table 86. Novartis Company Details
Table 87. Novartis Business Overview
Table 88. Novartis Product
Table 89. Novartis Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 90. Novartis Recent Development
Table 91. Alimera Sciences Company Details
Table 92. Alimera Sciences Business Overview
Table 93. Alimera Sciences Product
Table 94. Alimera Sciences Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 95. Alimera Sciences Recent Development
Table 96. Teva Pharmaceutical Company Details
Table 97. Teva Pharmaceutical Business Overview
Table 98. Teva Pharmaceutical Product
Table 99. Teva Pharmaceutical Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 100. Teva Pharmaceutical Recent Development
Table 101. Eyetech Pharmaceuticals Company Details
Table 102. Eyetech Pharmaceuticals Business Overview
Table 103. Eyetech Pharmaceuticals Product
Table 104. Eyetech Pharmaceuticals Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 105. Eyetech Pharmaceuticals Recent Development
Table 106. Refocus Group Company Details
Table 107. Refocus Group Business Overview
Table 108. Refocus Group Product
Table 109. Refocus Group Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 110. Refocus Group Recent Development
Table 111. VisionCare Ophthalmic Technologies Company Details
Table 112. VisionCare Ophthalmic Technologies Business Overview
Table 113. VisionCare Ophthalmic Technologies Product
Table 114. VisionCare Ophthalmic Technologies Revenue in Eye Disorders Treatments Business (2015-2020) (Million US$)
Table 115. VisionCare Ophthalmic Technologies Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global Eye Disorders Treatments Market Share by Type: 2020 VS 2026
Figure 2. Cataract Surgery Devices Features
Figure 3. Glaucoma Surgery Devices Features
Figure 4. Vitreoretinal Surgery Devices Features
Figure 5. Refractive Surgery Devices Features
Figure 6. Global Eye Disorders Treatments Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Eye Disorders Treatments Report Years Considered
Figure 11. Global Eye Disorders Treatments Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Eye Disorders Treatments Market Share by Regions: 2020 VS 2026
Figure 13. Global Eye Disorders Treatments Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Eye Disorders Treatments Market Share by Players in 2019
Figure 16. Global Top Eye Disorders Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eye Disorders Treatments as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Eye Disorders Treatments Revenue in 2019
Figure 18. North America Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Johnson & Johnson Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 27. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Novartis Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 29. Alimera Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Alimera Sciences Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 31. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Teva Pharmaceutical Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 33. Eyetech Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Eyetech Pharmaceuticals Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 35. Refocus Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Refocus Group Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 37. VisionCare Ophthalmic Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. VisionCare Ophthalmic Technologies Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
Figure 1. Global Eye Disorders Treatments Market Share by Type: 2020 VS 2026
Figure 2. Cataract Surgery Devices Features
Figure 3. Glaucoma Surgery Devices Features
Figure 4. Vitreoretinal Surgery Devices Features
Figure 5. Refractive Surgery Devices Features
Figure 6. Global Eye Disorders Treatments Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Others Case Studies
Figure 10. Eye Disorders Treatments Report Years Considered
Figure 11. Global Eye Disorders Treatments Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Eye Disorders Treatments Market Share by Regions: 2020 VS 2026
Figure 13. Global Eye Disorders Treatments Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Eye Disorders Treatments Market Share by Players in 2019
Figure 16. Global Top Eye Disorders Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Eye Disorders Treatments as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Eye Disorders Treatments Revenue in 2019
Figure 18. North America Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Eye Disorders Treatments Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Johnson & Johnson Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 27. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Novartis Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 29. Alimera Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Alimera Sciences Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 31. Teva Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Teva Pharmaceutical Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 33. Eyetech Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Eyetech Pharmaceuticals Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 35. Refocus Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Refocus Group Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 37. VisionCare Ophthalmic Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. VisionCare Ophthalmic Technologies Revenue Growth Rate in Eye Disorders Treatments Business (2015-2020)
Figure 39. Bottom-up and Top-down Approaches for This Report
Figure 40. Data Triangulation
Figure 41. Key Executives Interviewed
